Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A phase I, multiple-dose study of SA237 in rheumatoid arthritis
jRCT2080221744Phase 1
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, single-arm trial of satralizumab in rheumatoid arthritis (RA), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
satralizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080221744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221744.